Inventor · disambiguated record
Christopher Graham Raphael Parsons
Also filed as: PARSONS CHRISTOPHER · PARSONS CHRISTOPHER G R · PARSONS CHRISTOPHER GRAHAM RAP · PARSONS CHRISTOPHER GRAHAM RAPHAEL
12 granted patents·7 pending applications·360 citations·filing 1996–2013
90Inventor score
Files withMERZ PHARMA GMBH & CO KGAA14MERZ & CO GMBH & CO3HENRICH MARKUS1RAMOT AT TEL-AVIV UNIV LTD1
Top patents by PatentIndex Score
19 records- 0196US6034134A1-Amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Mar 7, 2000·238 cites·22 claims
- 0284US6071966A1-amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Jun 6, 2000·74 cites·12 claims
- 0380US7985753B2Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Jul 26, 2011·6 cites·19 claims
- 0478US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 0571US9717772B2Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2013·Granted Aug 1, 2017·2 cites·15 claims
- 0669US7947689B2Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted May 24, 2011·1 cites·19 claims
- 0767US7598384B2Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Oct 6, 2009·1 cites·77 claims
- 0866US2009081259A11-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affectMERZ PHARMA GMBH & CO KGAA·Filed 2008·Application pending·0 cites
- 0962US7022729B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2003·Granted Apr 4, 2006·1 cites·3 claims
- 1061US5776935APyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmissionMERZ & CO GMBH & CO·Filed 1996·Granted Jul 7, 1998·22 cites·12 claims
- 1157US8288549B2Glycine B antagonistHENRICH MARKUS·Filed 2009·Granted Oct 16, 2012·1 cites·12 claims
- 1255US7238703B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jul 3, 2007·0 cites·3 claims
- 1353US7550482B2Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jun 23, 2009·0 cites·11 claims
- 1447US2011212956A1Pyrazolopyrimidines for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2011·Application pending·0 cites
- 1545US2007299113A1Metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 1643US2010298442A11-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2010·Application pending·0 cites
- 1743US2010190751A1Novel combination of neramexane for treatment of nerordegeneratie disordersMERZ PHARMA GMBH & CO KGAA·Filed 2008·Application pending·0 cites
- 1842US2006004001A1Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 1938US2006074083A1Cyclic and acyclic propenones for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Graham Raphael Parsons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →